The Ethical Investor: Sustainability top of the agenda but enthusiasm not being matched by progre...
And now for a Chinese e-commerce war
Why all eyes are on Neuren Pharmaceuticals as it awaits crucial FDA approval in March
Breakfast on Wall St: NVDA snaps streak as shares pop on cracking AI outlook
MoneyTalks: Two potential big buys in the education space
Guy on Rocks: All aboard the PMT train!
Q&A: It’s Technology Metals’ time to shine with vanadium demand set to double by 2032
Who could be the ASX fintech winners as Aussies chase a better banking deal in 2023?
Super profits may be gone for now, but Rio Tinto sees energy transition powering commodity demand...
Weed Week: Musk gives the go-ahead for cannabis advertising on Twitter in the US